Cedilla Therapeutics

Cedilla Therapeutics

Biotechnology Research 245 First Street 6 employees
Employees
6
Contacts
1
Emails
1
Phones
1

Cedilla Therapeutics Overview

Headquarters
245 First Street
Website
cedillatx.com
Industry
Biotechnology Research
Employees
6
Founded
2018
Funding
25.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Cedilla Therapeutics

For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.

Cedilla Therapeutics Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage
Phone contacts
1
50.0% coverage

Cedilla Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Alan D'andrea Professor, Harvard Medical School
Email Phone
Nayan Chavda Manager at Cedilla Therapeutics
View

Employees by Management Level

Individual contributor 4 profiles
Manager 1 profile

Compare Similar Companies to Cedilla Therapeutics